HER2-dependent MMP-7 expression is mediated by activated STAT3

Cellular Signalling

Volumn 20, Issue 7, 2008, Pages 1284-1291

  Yuan, Guogang ^a   Qian, Lu ^a   Shi, Ming ^a   Lu, Feng ^b   Li, Dan ^a   Hu, Meiru ^a   Yu, Ming ^a   Shen, Beifen ^a   Guo, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

Author keywords

Cancer; HER2; Heregulin; MMP 7; STAT3

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MATRILYSIN; MESSENGER RNA; STAT3 PROTEIN;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVITY; GENE SEQUENCE; HUMAN; HUMAN CELL; MUTAGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 7; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NEUREGULIN-1; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-2; STAT3 TRANSCRIPTION FACTOR;

EID: 43049183421     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2008.02.017     Document Type: Article

References (43)

1. Liotta L.A., and Kohn E.C. J. Natl. Cancer Inst. 94 (2002) 1113
2. Overall C.M., and López-Otín C. Nat. Rev., Cancer 2 (2002) 657
3. Deryugina E.I., and Quigley J.P. Cancer Metastasis Rev. 25 (2006) 9
4. Shiomi T., and Okada Y. Cancer Metastasis Rev. 22 (2003) 145
5. Wielockx B., Libert C., and Wilson C. Cytokine Growth Factor Rev. 15 (2004) 111
6. Yamamoto H., Adachi Y., Itoh F., Iku S., Matsuno K., Kusano M., Arimura Y., Endo T., Hinoda Y., Hosokawa M., and Imai K. Cancer Res. 59 (1999) 3313
7. Powell W.C., Knox J.D., Navre M., Grogan T.M., Kittelson J., Nagle R.B., and Bowden G.T. Cancer Res. 53 (1993) 417
8. Pacheco M.M., Kowalski L.P., Nishimoto I.N., and Brentani M.M. Head Neck 24 (2002) 24
9. Heppner K.J., Matrisian L.M., Jensen R.A., and Rodgers W.H. Am. J. Pathol. 149 (1996) 273
10. Bolon I., Devouassoux M., Robert C., Moro D., Brambilla C., and Brambilla E. Am. J. Pathol. 150 (1997) 1619
11. Lynch C.C., Hikosaka A., Acuff H.B., Martin M.D., Kawai N., Singh R.K., Vargo-Gogola T.C., Begtrup J.L., Peterson T.E., Fingleton B., Shirai T., Matrisian L.M., and Futakuchi M. Cancer Cell 7 (2005) 485
12. Yamamoto H., Adachi Y., Itoh F., Iku S., Matsuno K., Kusano M., Arimura Y., Endo T., Hinoda Y., Hosokawa M., and Imai K. Cancer Res. 59 (1999) 3313
13. Adachi Y., Itoh F., Yamamoto H., Matsuno K., Arimura Y., Kusano M., Endoh T., Hinoda Y., Oohara M., Hosokawa M., and Imai K. Int. J. Oncol. 13 (1998) 1031
14. Graesslin O., Cortez A., Fauvet R., Lorenzato M., Birembaut P., and Daraï E. Ann. Oncol. 17 (2006) 637
15. Tanimoto H., Underwood L.J., Shigemasa K., Parmley T.H., Wang Y., Yan Y., Clarke J., and O'Brien T.J. Tumour Biol. 20 (1999) 88
16. Soreide K., Janssen E.A., Körner H., and Baak J.P. J. Pathol. 209 (2006) 147
17. Kioi M., Yamamoto K., Higashi S., Koshikawa N., Fujita K., and Miyazaki K. Oncogene 22 (2003) 8662
18. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L., and Matrisian L.M. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1402
19. Hulboy D.L., Gautam S., Fingleton B., and Matrisian L.M. Oncol. Rep. 12 (2004) 13
20. Wang W.S., Chen P.M., Wang H.S., Liang W.Y., and Su Y. Carcinogenesis 27 (2006) 1113
21. Westermarck J., and Kähäri V.M. Faseb J. 13 (1999) 781
22. Gaire M., Magbanua Z., McDonnell S., McNeil L., Lovett D.H., and Matrisian L.M. J. Biol. Chem. 269 (1994) 2032
23. Wasylyk B., Hagman J., and Gutierrez-Hartmann A. Trends Biochem. Sci. 23 (1998) 213
24. Wisdom R. Exp. Cell Res. 253 (1999) 180
25. O'Hagan R.C., and Hassell J.A. Oncogene 16 (1998) 301
26. O-charoenrat P., Rhys-Evans P.H., Archer D.J., and Eccles S.A. Oral Oncol. 38 (2002) 73
27. Lynch C.C., Crawford H.C., Matrisian L.M., and McDonnell S. Int. J. Oncol. 24 (2004) 1565
28. Qian L., Chen L., Shi M., Yu M., Jin B., Hu M., Xia Q., Zhang X., Shen B., and Guo N. Biochem. Biophys. Res. Commun. 345 (2006) 660
29. Alper O., Bergmann-Leitner E.S., Bennett T.A., Hacker N.F., Stromberg K., and Stetler-Stevenson W.G. J. Natl. Cancer Inst. 93 (2001) 1375
30. Bosc D.G., Goueli B.S., and Janknecht R. Oncogene 20 (2001) 6215
31. Pellikainen J.M., Ropponen K.M., Kataja V.V., Kellokoski J.K., Eskelinen M.J., and Kosma V.M. Clin. Cancer Res. 10 (2004) 7621
32. Yen L., You X.L., Al Moustafa A.E., Batist G., Hynes N.E., Mader S., Meloche S., and Alaoui-Jamali M.A. Oncogene 19 (2000) 3460
33. Yao J., Xiong S., Klos K., Nguyen N., Grijalva R., Li P., and Yu D. Oncogene 20 (2001) 8066
34. Tang F.Y., Chiang E.P., and Sun Y.C. J. Nutr. Biochem (2007) [Electronic publication ahead of print]
35. Song Y., Qian L., Song S., Chen L., Zhang Y., Yuan G., Zhang H., Xia Q., Hu M., Yu M., Shi M., Jiang Z., and Guo N. Mol. Immunol. 45 (2008) 137
36. Fernandes A., Hamburger A.W., and Gerwin B.I. Int. J. Cancer 83 (1999) 564
37. Holnthoner W., Kerenyi M., Gröger M., Kratochvill F., and Petzelbauer P. Biochem. Biophys. Res. Commun. 342 (2006) 725
38. Normanno N., Kim N., Wen D., Smith K., Harris A.L., Plowman G., Colletta G., Ciardiello F., and Salomon D.S. Breast Cancer Res. Treat. 35 (1995) 293
39. Huang S. Clin. Cancer Res. 13 (2007) 1362
40. Page C., Huang M., Jin X., Cho K., Lilja J., Reynolds R.K., and Lin J. Int. J. Oncol. 17 (2000) 23
41. Watson C.J., and Miller W.R. Br. J. Cancer 71 (1995) 840
42. Mitsiades N., Yu W.H., Poulaki V., Tsokos M., and Stamenkovic I. Cancer Res. 61 (2001) 577
43. Hynes N.E., and Stern D.F. Biochim. Biophys. Acta 1198 (1994) 165